Researchers apply IGF-1 LR3 to investigate its structural modifications that dramatically decrease affinity for IGF-binding proteins, resulting in prolonged plasma half-life and sustained receptor activation compared to native IGF-1. Pre-clinical observations in rodent overload and injury models indicate enhanced satellite cell proliferation, increased muscle cross-sectional area, and promotion of hyperplasia and hypertrophy through augmented Akt/mTOR signaling.
This analog facilitates examination of extended anabolic signaling duration, localized and systemic regenerative effects, and interactions with myostatin pathways in muscle physiology research.
Scientific Overview of IGF-1 LR3 Applications
Pre-clinical models highlight IGF-1 LR3’s enhanced receptor engagement:
- Reduced binding to IGFBPs and 3–10× increased potency at the IGF-1 receptor, leading to sustained downstream Akt/mTOR pathway activation in skeletal muscle systems.
- Promotion of muscle hyperplasia (new fiber formation) and hypertrophy (fiber size increase) in overload and injury rodent models.
- Enhancement of satellite cell proliferation and delayed differentiation, supporting prolonged regenerative phases in muscle damage paradigms.
- Support for glucose and fatty acid uptake, with inhibition of myostatin expression in metabolic and anabolic research contexts.
- Neuroprotective effects in brain injury models through upregulation of BDNF and related survival signaling.
- Examination of tissue-specific IGF-1 signaling contributions in sarcopenia, muscular dystrophy, wound healing, and performance physiology studies.
For further details on IGF-1 analogs, receptor signaling, and regenerative pathways in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Why Investigators Select National Science Labs IGF-1 LR3
National Science Labs manufactures IGF-1 LR3 under stringent GMP-compliant protocols to ensure batch-to-batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:
- Purity ≥99.9% by HPLC and MS
- Structural identity confirmation via mass spectrometry (full sequence and modifications)
- Complete Certificate of Analysis (CoA) documentation provided per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this peptide have not been evaluated by the FDA.
Initiate Your IGF-1 LR3 Research Protocol
Source high-purity IGF-1 LR3 from current limited batches to ensure optimal stability and performance in IGF-1 receptor and anabolic signaling studies.
